04/17/2024
6:36 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
5:50 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:58 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:32 PM | Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/02/2024
5:40 PM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:09 PM | Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:14 PM | Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/04/2024
6:18 PM | Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:22 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:56 PM | Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:00 PM | Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
6:05 PM | Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:39 PM | Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:44 PM | Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:50 PM | Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
4:53 PM | Abbott Laboratories (Subject)
Salvadori Daniel Gesua Sive (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:39 PM | Abbott Laboratories (Subject)
Moreland Mary K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:45 PM | Abbott Laboratories (Subject)
Morrone Louis H. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:22 PM | Abbott Laboratories (Subject)
ALLEN HUBERT L (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:25 PM | Abbott Laboratories (Subject)
Earnhardt Lisa D (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/01/2024
4:32 PM | Abbott Laboratories (Subject)
MCCOY JOHN A. JR. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024
5:13 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:45 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:35 PM | Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:38 PM | Abbott Laboratories (Issuer)
Moreland Mary K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:40 PM | Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:43 PM | Abbott Laboratories (Issuer)
Salvadori Daniel Gesua Sive (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:27 PM | Abbott Laboratories (Issuer)
Ford Robert B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:29 PM | Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:33 PM | Abbott Laboratories (Issuer)
Earnhardt Lisa D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:23 PM | Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/23/2024
4:03 PM | Abbott Laboratories (Issuer)
ALLEN HUBERT L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/16/2024
3:15 PM | Abbott Laboratories (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
01/31/2024
4:30 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
3:04 PM | Abbott Laboratories (Subject)
Wainer Andrea F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/24/2024
6:36 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2024
4:38 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:28 PM | Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:30 PM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2024
4:33 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
4:36 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Your Money is Not Safe (Ad) Biden Deploys Phase 1 Fednow Digital Currency
Discover how to legally "opt-out" of the digital dollar today.
No matter what they say, it's not something that will help you.
If you don't take the action steps shown below… CLICK HERE TO GET YOUR GUIDE NOW |
10/18/2023
6:37 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2023
5:45 PM | Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
5:46 PM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
5:48 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2023
5:49 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/15/2023
4:35 PM | Abbott Laboratories (Issuer)
Funck, Jr. Robert E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
5:48 PM | Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/06/2023
5:50 PM | Abbott Laboratories (Issuer)
MCCOY JOHN A. JR. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/06/2023
5:53 PM | Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
3:13 PM | Abbott Laboratories (Filer)
| Form 8-K/A | |
08/10/2023
5:31 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/28/2023
4:10 PM | Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/20/2023
7:29 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/05/2023
10:54 AM | Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
10:55 AM | Abbott Laboratories (Issuer)
Morrone Louis H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
10:56 AM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
10:57 AM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/05/2023
10:57 AM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/23/2023
3:07 PM | Abbott Laboratories (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/20/2023
5:55 PM | Abbott Laboratories (Issuer)
Boudreau Philip P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2023
2:18 PM | Abbott Laboratories (Subject)
Boudreau Philip P (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2023
9:32 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2023
6:09 PM | Abbott Laboratories (Issuer)
Wainer Andrea F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2023
5:13 AM | Abbott Laboratories (Filer)
| Form S-3ASR | |
05/02/2023
6:57 PM | Abbott Laboratories (Issuer)
McKinstry Nancy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:59 PM | Abbott Laboratories (Issuer)
O'Grady Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
7:02 PM | Abbott Laboratories (Issuer)
Roman Michael F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
7:04 PM | Abbott Laboratories (Issuer)
STARKS DANIEL J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
7:08 PM | Abbott Laboratories (Issuer)
Stratton John G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:51 PM | Abbott Laboratories (Issuer)
Gonzalez Patricia Paola (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:53 PM | Abbott Laboratories (Issuer)
Kumbier Michelle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:55 PM | Abbott Laboratories (Issuer)
McDew Darren W (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:33 PM | Abbott Laboratories (Issuer)
O'Grady Michael (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/02/2023
6:34 PM | Abbott Laboratories (Subject)
MANNING JOSEPH J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2023
6:37 PM | Abbott Laboratories (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:39 PM | Abbott Laboratories (Issuer)
Babineaux-Fontenot Claire (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:42 PM | Abbott Laboratories (Issuer)
Blount Sally E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2023
6:01 PM | Abbott Laboratories (Subject)
Wainer Andrea F (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2023
6:26 PM | Abbott Laboratories (Subject)
WOODGRIFT RANDEL WILLIAM (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2023
2:25 PM | Abbott Laboratories (Subject)
STARKS DANIEL J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/02/2023
5:00 AM | Abbott Laboratories (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
